Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Galderma S.A.
DescriptionHyaluronic acid dermal filler plus 0.3% lidocaine
Molecular Target
Mechanism of Action 
Therapeutic ModalityMacromolecule: Polysaccharide
Latest Stage of DevelopmentMarketed
Standard IndicationScars / wrinkles
Indication DetailsCorrect moderate to severe facial wrinkles and folds
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today